Clinical research logistics in ophthalmic trials are not just about moving equipment or scheduling visits. They directly affect endpoint quality. When intraocular pressure (IOP), best corrected visual acuity (BCVA), optical coherence tomography (OCT), fundus photography, or visual fields depend on trained personnel, calibrated devices, and participant attendance, every logistics gap becomes a potential data and protocol risk.
For these reasons, improving clinical research logistics must be at the center of your study planning. A hybrid execution model utilizing point-of-need delivery addresses these recurring issues. This approach overcomes the main physical challenges of ophthalmic trials, safeguarding data integrity and protocol adherence.
This article will explore how specialized ophthalmic field execution can protect your study from operational failures.
There are numerous potential challenges in ophthalmic trials. Medical equipment delays, for instance, can impact data collection, while scheduling conflicts with healthcare providers and assessors could further impact timelines.
Additionally, patients who have practical difficulties traveling to research sites may miss visits. This can lead to skewed data and other challenges that call the clinical results into question.
Likewise, protocol deviations in clinical studies can impact patient safety and data quality. Non-adherence can compromise the validity of the study and lead to regulatory consequences. Protocol deviations are among the most common reasons the FDA may get involved in a study.
Clinical research logistics is a potential point of failure of particular concern. When clinical trial logistics start to break down, there may be delays, protocol deviations, and issues with participant satisfaction.
As soon as logistics become an issue, subsequent delays can result in missed patient visits. The same may occur if assessments have to be repeated due to protocol failures.
When patients are absent and retention levels drop, data gaps begin to form. It may be necessary to recruit more participants, which isn’t a cost-effective option and can cause further delays. Taken together, these effects could completely upend the timeline of your study.
Clinical research logistics are particularly challenging in ophthalmic trials due to specific requirements that must be met.
Equipment logistics is a foremost concern. Your trial may require calibrated OCT devices, tonometers, and specialized imaging equipment. These tools must be transported to the appropriate research site in a timely manner and calibrated properly so researchers can put them to immediate use.
You’ll also need to deploy certified ophthalmic technicians to trial sites. Coordinating schedules can be difficult, but failing to do so may mean patients won’t receive necessary assessments when they should.
Clinical research logistics related to participants are among the most challenging issues a trial can face. Getting participants to take part in assessments means ensuring that they visit the trial site when scheduled. In some instances, there could be direct-to-patient options that ease the travel burden, but they, too, demand effective logistics management.
Trials with ocular endpoints have specific requirements, including the need for precise equipment and participant accessibility. These are all considerations that a specialized execution partner must be ready to address.
20/20 Onsite offers specialized field execution designed to fix these operational issues. Depending on the nature of your study, one of the most effective options is to deploy point-of-need, mobile clinics.
This point-of-need delivery model helps to reach participants where they live, work, or spend time. By utilizing mobile clinics, it’s possible to eliminate one of the biggest friction points for many trial participants: the need to travel to the research site.
Our mobile clinic option effectively reduces patients’ travel needs. With the implementation of mobile clinics, participants’ average travel distance is 12 miles, compared with the industry standard of 67 miles. These solutions also make it possible to reduce dropout rates to just 9%, while the industry standard is 30%.
When you turn to 20/20 Onsite, you’ll also benefit from single-call accountability. You’ll work with one partner, who will handle timely deliveries, inventory management, equipment deployment, and execution logistics. This level of responsiveness can streamline the trial and ensure that you always know who to contact if concerns arise.
Strategic project management helps you avoid potential pitfalls in your study. You can eliminate the risk of clinician no-shows, equipment-transport hang-ups, and barriers to participant travel.
Mobile vision clinics (MVCs) are operated by experienced, certified clinicians and stocked with calibrated equipment. They can help you meet key regulatory requirements while enhancing functionality and easing pressure on patients.
A notable advantage of the 20/20 Onsite model is that it doesn’t impact CRO setups. CROs will handle trial coordination, while our team oversees ophthalmic logistics, including the integration of mobile delivery. As a specialized execution partner, our goal isn't to replace what works. We simply eliminate physical bottlenecks to improve efficiency.
Flexible executions can transform your clinical trial. Participants may be able to receive home visits or assessments at work. Community centers are also excellent places to deploy mobile clinics.
Equipment logistics issues are common in site-based trials. There may be maintenance delays or calibration gaps that threaten assessment windows. Additionally, it may be harder to avoid device variability across different locations, which presents significant data concerns.
Site-based trials can create personnel problems as well. Putting together schedules of certified ophthalmic assessors requires careful planning and coordination. At the same time, training gaps may exist that undermine the integrity of the data collected.
And, as mentioned, some participants may not be able to keep up with their visits if they don’t have reliable transportation or depend on caregivers to accompany them.
These obstacles can result in missed visit windows, which could put you at risk of audits. Your overall timeline could be affected, leading to additional expenses. If there are protocol deviations, you may be in danger of losing regulatory compliance and collecting incomplete data.
When participant dropout rates increase, so do your expenses. Replacing just one participant can cost as much as $19,533.
The clinical solutions 20/20 Onsite offers can substantially curb dropout rates. They can also help prevent screening failures, so you can be sure that each of your participants will benefit the trial and benefit from the trial.
Logistics failures could cost you anywhere from $600,000 to $8 million in future sales. Vendor-coordination costs will only add to these losses. These costs and risks can be minimized with single-call accountability.
The therapeutic need for each trial will determine whether scaling the operational solutions is necessary. For example, it may not be practical for people spread out across the nation to participate in rare disease studies at one specific geographic location. Those with rare eye conditions may therefore benefit from mobile clinics placed throughout the country.
These trials typically require years of participation and can involve numerous states or observational areas. Having a clinic in their city can reduce the burden on study participants and ultimately make for a stronger trial.
Importantly, operational solutions like these can go a long way toward promoting healthcare equity. For instance, diabetic health issues frequently affect lower-income people who potentially can’t afford to travel to trial sites.
When deciding on the right operational solutions, look for an execution partner that provides ophthalmic-specific services. They should offer trained personnel with relevant experience, standardized data capture methods, and calibrated equipment.
Seek out point-of-need execution options, not just traditional one-site services. These services will provide the flexibility your trial and its participants need.
Insist on single-call accountability to streamline core processes. With this set-up, one partner owns the entire logistics-execution cycle, making it much easier to manage the trial.
Integrating these clinical trial solutions should be simple and straightforward. CRO operations can be enhanced rather than replaced, and workflows need not be disrupted.
If you’re planning on running a trial that hinges on nationwide participation, scalability is everything. Make sure the field execution partner you choose can accommodate these physical and operational needs.
Everything breaks down if operations fail during clinical studies. Participants can start dropping out, leaving you with incomplete data, and delays can quickly steer the trial off course. 20/20 Onsite offers clinical trial execution services you can rely on.
Our service model can help eliminate the risks associated with traditional one-site trials by emphasizing point-of-need execution. This reduces participant burden while helping sponsors preserve assessment consistency, protocol adherence, and data quality.
If you’re worried about avoidable risks impacting your study, contact our team today to schedule a protocol review and risk assessment. With our expertise and support, you can avoid equipment, personnel, and participant-related vulnerabilities.